These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30444288)

  • 1. Reactivity of CK7 across the spectrum of renal cell carcinomas with clear cells.
    Gonzalez ML; Alaghehbandan R; Pivovarcikova K; Michalova K; Rogala J; Martinek P; Foix MP; Mundo EC; Comperat E; Ulamec M; Hora M; Michal M; Hes O
    Histopathology; 2019 Mar; 74(4):608-617. PubMed ID: 30444288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic clear cell renal cell carcinoma with diffuse cytokeratin 7 immunoreactivity.
    Mai KT; Kohler DM; Belanger EC; Robertson SJ; Wang D
    Pathology; 2008 Aug; 40(5):481-6. PubMed ID: 18604734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics.
    Mantilla JG; Antic T; Tretiakova M
    Hum Pathol; 2017 Aug; 66():152-158. PubMed ID: 28705707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.
    Williamson SR; Halat S; Eble JN; Grignon DJ; Lopez-Beltran A; Montironi R; Tan PH; Wang M; Zhang S; Maclennan GT; Baldridge LA; Cheng L
    Am J Surg Pathol; 2012 Oct; 36(10):1425-33. PubMed ID: 22982885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features.
    Alshenawy HA
    Pathol Oncol Res; 2015 Sep; 21(4):893-9. PubMed ID: 25712789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic clear cell papillary renal cell carcinoma: is it related to multilocular clear cell cystic neoplasm of low malignant potential?
    Brimo F; Atallah C; Li G; Srigley JR
    Histopathology; 2016 Apr; 68(5):666-72. PubMed ID: 26256827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma with mixed features of papillary and clear cell cytomorphology: a fluorescent in situ hybridization study.
    Mai KT; Faraji H; Desantis D; Robertson SJ; Belanger EC; Levac J
    Virchows Arch; 2010 Jan; 456(1):77-84. PubMed ID: 20033232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker.
    Martignoni G; Brunelli M; Segala D; Munari E; Gobbo S; Cima L; Borze I; Wirtanen T; Sarhadi VK; Atanesyan L; Savola S; Barzon L; Masi G; Fassan M; Eble JN; Bohling T; Cheng L; Delahunt B; Knuutila S
    Pathology; 2017 Jan; 49(1):10-18. PubMed ID: 27923499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role Of Immunohistochemistry In Subtyping Renal Cell Carcinomas With Overlapping Morphological Features.
    Tariq N; Mamoon N; Haroon A; Ali Z; Ahmad IN
    J Ayub Med Coll Abbottabad; 2018; 30(3):325-332. PubMed ID: 30465359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of parafibromin in clear cell papillary renal cell carcinoma.
    Cui C; Ziober A; Bing Z
    Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):322-5. PubMed ID: 23060304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis.
    Williamson SR; Gupta NS; Eble JN; Rogers CG; Michalowski S; Zhang S; Wang M; Grignon DJ; Cheng L
    Am J Surg Pathol; 2015 Nov; 39(11):1502-10. PubMed ID: 26457355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
    Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
    Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Clear Cell Papillary Renal Cell Carcinoma in Low-Grade Renal Cell Carcinoma Cases: A 12-Year Retrospective Clinicopathologic Study From a Single Cancer Center.
    Gill S; Kauffman EC; Kandel S; George S; Schwaab T; Xu B
    Int J Surg Pathol; 2016 May; 24(3):207-12. PubMed ID: 26510859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic papillary renal cell carcinoma is a rare morphological variant with frequent multifocality: a study of 28 cases.
    Trpkov K; Athanazio D; Magi-Galluzzi C; Yilmaz H; Clouston D; Agaimy A; Williamson SR; Brimo F; Lopez JI; Ulamec M; Rioux-Leclercq N; Kassem M; Gupta N; Hartmann A; Leroy X; Bashir SA; Yilmaz A; Hes O
    Histopathology; 2018 Apr; 72(5):777-785. PubMed ID: 29119638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
    Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
    Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Categorizing renal oncocytic neoplasms on core needle biopsy: a morphologic and immunophenotypic study of 144 cases with clinical follow-up.
    Alderman MA; Daignault S; Wolf JS; Palapattu GS; Weizer AZ; Hafez KS; Kunju LP; Wu AJ
    Hum Pathol; 2016 Sep; 55():1-10. PubMed ID: 27085554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillary pattern in clear cell renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 23 cases.
    Alaghehbandan R; Ulamec M; Martinek P; Pivovarcikova K; Michalova K; Skenderi F; Hora M; Michal M; Hes O
    Ann Diagn Pathol; 2019 Feb; 38():80-86. PubMed ID: 30502717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomorphology of clear cell papillary renal cell carcinoma.
    Lin X
    Cancer Cytopathol; 2017 Jan; 125(1):48-54. PubMed ID: 27636377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.